| Filed On | Filing |
|---|---|
| 15 May 2017 |
Form 3: Germano Geno J, Director
No securities owned |
| 11 Apr 2017 |
Form 3: Harris Timothy J.r., EVP, R & D
Holds 81 shares of Common Stock |
| 02 Mar 2017 |
Form 3: Protopapas Anna, Director
No securities owned |
| 01 Feb 2017 |
Form 3: Duvall Diantha, Chief Accounting Officer
No securities owned |
| 19 Jan 2017 |
Form 3: Paglia Louis J, Director
Holds 0 shares of Common Stock |
| 19 Jan 2017 |
Form 3: Posner Brian S, Director
Holds 0 shares of Common Stock |
| 19 Jan 2017 |
Form 3: Denner Alexander J, Director
Holds 0 shares of Common Stock |
| 22 Dec 2016 |
Form 3: Biogen Inc., 10% owner
Holds 1,000 shares of Common Stock |
| 22 Dec 2016 |
Form 3: Greene John, EVP, CFO and Treasurer
Holds 0 shares of Common Stock |
| 22 Dec 2016 |
Form 3: Vivaldi Coelho Rogerio, EVP, Chief Global Therapeutics
Holds 0 shares of Common Stock |
| 22 Dec 2016 |
Form 3: Celona Lucia, EVP, HR & Corp Commun. Officer
Holds 0 shares of Common Stock |
| 22 Dec 2016 |
Form 3: Brudnick Richard, EVP, Business Development
Holds 0 shares of Common Stock |
| 22 Dec 2016 |
Form 3: DiFabio Andrea, EVP, Chief Legal Officer
Holds 0 shares of Common Stock |
| 22 Dec 2016 |
Form 3: Cox John, Director
Holds 0 shares of Common Stock |
Loading...